BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17674979)

  • 81. Update on chemoradiotherapy for head and neck cancer.
    Argiris A
    Curr Opin Oncol; 2002 May; 14(3):323-9. PubMed ID: 11981279
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Update of human spinal cord reirradiation tolerance based on additional data from 38 patients.
    Nieder C; Grosu AL; Andratschke NH; Molls M
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1446-9. PubMed ID: 17084560
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules.
    Fowler JF; Harari PM; Leborgne F; Leborgne JH
    Radiother Oncol; 2003 Nov; 69(2):161-8. PubMed ID: 14643953
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Does altered fractionation influence the risk of radiation-induced optic neuropathy?
    Bhandare N; Monroe AT; Morris CG; Bhatti MT; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1070-7. PubMed ID: 15990010
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Controlled trials of synchronous chemotherapy with radiotherapy in head and neck cancer: overview of radiation morbidity.
    Henk JM
    Clin Oncol (R Coll Radiol); 1997; 9(5):308-12. PubMed ID: 9368726
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Application of the linear-quadratic model to combined modality radiotherapy.
    Bodey RK; Evans PM; Flux GD
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):228-41. PubMed ID: 15093920
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Dose fractionation in distance radiotherapy of malignant neoplasms].
    Kozlov AP; Akimov AA
    Vopr Onkol; 1983; 29(11):105-16. PubMed ID: 6359680
    [No Abstract]   [Full Text] [Related]  

  • 88. Advances in radiotherapy of head and neck cancers.
    Tao Y; Daly-Schveitzer N; Lusinchi A; Bourhis J
    Curr Opin Oncol; 2010 May; 22(3):194-9. PubMed ID: 20401975
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Investigation of relationship between change in locoregional control and change in overall survival in randomized controlled trials of modified radiotherapy in head-and-neck cancer.
    Wadsley JC; Bentzen SM
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1405-9. PubMed ID: 15590171
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Radiotherapy plus chemotherapy for head and neck cancer.
    Morgan DA
    N Engl J Med; 1993 Feb; 328(8):579; author reply 580. PubMed ID: 8426628
    [No Abstract]   [Full Text] [Related]  

  • 91. Does response to induction chemotherapy (IC) predict locoregional control after concurrent chemoradiotherapy (CCRT) in locally advanced head and neck cancer (LAHNC)?
    Cotter R; Blacksburg S; Carpenter T; Kann B; Bakst R; Misiukiewicz K; Posner M; Som P; Gupta V
    Oral Oncol; 2014 Jun; 50(6):e27-8. PubMed ID: 24680084
    [No Abstract]   [Full Text] [Related]  

  • 92. Role of adjuvant radiotherapy in recurrent earlobe keloids.
    Dinh Q; Veness M; Richards S
    Australas J Dermatol; 2004 Aug; 45(3):162-6. PubMed ID: 15250893
    [TBL] [Abstract][Full Text] [Related]  

  • 93. International Clinical Trials in Radiation Oncology. Head and neck: cancer research plan.
    Marcial VA; van den Bogaert W; Horiot JC
    Int J Radiat Oncol Biol Phys; 1988; 14 Suppl 1():S119-25. PubMed ID: 3292469
    [No Abstract]   [Full Text] [Related]  

  • 94. Fluctuations in pO2 in poorly and well-oxygenated spontaneous canine tumors before and during fractionated radiation therapy.
    Brurberg KG; Skogmo HK; Graff BA; Olsen DR; Rofstad EK
    Radiother Oncol; 2005 Nov; 77(2):220-6. PubMed ID: 16257074
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Combination chemotherapy and radiation therapy for upper aerodigestive tract cancers.
    Shafman TD
    Med Health R I; 2006 Feb; 89(2):55-8. PubMed ID: 16583662
    [No Abstract]   [Full Text] [Related]  

  • 96. Can radiobiological parameters derived from squamous cell carcinoma of the head and neck be used to predict local control in anal cancer treated with chemoradiation?
    Pettit L; Meade S; Sanghera P; Glaholm J; Geh JI; Hartley A
    Br J Radiol; 2013 Jan; 86(1021):20120372. PubMed ID: 23239699
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Fractionation modification: a way to increase the biological dose?
    Ang KK
    Acta Otorhinolaryngol Belg; 1999; 53(3):227-30. PubMed ID: 10635398
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Head and neck cancer patients treated with chemo-radiotherapy require individualized oncology nutrition.
    Kiyomoto D
    J Am Diet Assoc; 2007 Mar; 107(3):412-5. PubMed ID: 17324658
    [No Abstract]   [Full Text] [Related]  

  • 99. Tables of equivalent dose in 2 Gy fractions: a simple application of the linear quadratic formula.
    Barton M
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):371-8. PubMed ID: 7836091
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Radiation Therapy Oncology Group. Research Plan 2002-2006. Head and Neck Cancer Committee.
    Ang K; Weber R; Vokes E; Trotti A; Chapman D; Cooper J; Forastiere A; Fu KK; Hammond E; Khuri F; Leveque FS; Leupold N; Eisbruch A; Mack C; Mukherji S; Pajak TF; Ridge JA;
    Int J Radiat Oncol Biol Phys; 2001; 51(3 Suppl 2):39-43. PubMed ID: 11641013
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.